No guesses, just successes by computational design

WHY?

The traditional approach to bring medicine to market is a slow and expensive process, costing upward of $1bn and often a decade or more of research. For all the effort it requires, only a small fraction of drugs produced will even achieve market approval. This industry needed a revolution.

DISRUPTIVE IDEA

Denovicon's mission is to bring better quality drugs to market faster and more affordably than existing methods allow. To do so, they've created a drug discovery platform that's powered by AI, machine learning, generative therapeutic design and which uses a physics-based approach to achieve the best results.

The platform is able to effectively and swiftly triage billions upon billions of molecules to identify the highest-quality opportunities for potential compounds. Leveraging a variety of technologies, they're then able to run an optimization process that streamlines these "hits" and speed up the drug discovery process more than was previously thought possible.

This approach enables Denovicon to save time and money and achieve higher rates of clinical success - and down the line, to produce better patient outcomes.

POSITIVE IMPACT ON SOCIETY

In 2019, heart disease was responsible for 33% of all deaths worldwide, while cancer accounted for 18%. Unfortunately, the long timeline and high failure rate of traditional drug discovery means many patients are left waiting for new medicines to arrive for these and many other diseases. By dramatically shortening the timeline and cutting associated costs while ensuring higher clinical success in clinic, Denovicon is increasing the number of quickly available and accessible high-quality medicines to patients.

BENEFITS TO USING THE 3DEXPERIENCE PLATFORM

Denovicon leverages BIOVIA software to continuously enhance and extend the capabilities of its own platform. The company uses Pipeline Pilot to create advanced custom workflows and for integration; Discovery Studio for physics-based small-molecule modeling; and Generative Therapeutic Design for multi-property optimization.

COLLABORATIVE & COLLECTIVE INTELLIGENCE

As a member of the lab, Denovicon benefits greatly from being exposed to a vast network of academic and research organizations, as well as other start-ups in the biotech and pharma space. While already an established member of the drug discovery industry, the company stands to gain valuable insights from the partnerships and mentorship opportunities the 3DEXPERIENCE lab offers.

Meet the team